Japanese English 中文

Sponsored Links

Tax Schemes for Medical Corporation M&A: Key Issues for Experts

📖 Approx. 10 min / Updated 2026.05.08

The Importance of Taxation in Medical Corporation M&A

M&A and business succession for medical corporations involve numerous unique issues distinct from general corporations. In particular, expertise in taxation, such as the valuation of equity interests, taxation methods for transfer consideration, and the application of corporate reorganization tax laws, is extremely important. When considering M&A for a medical institution, or for tax accountants, CPAs, and consultants supporting the business succession of their clients, it is necessary to accurately understand these tax issues and select the optimal scheme. This article explains the main tax schemes in medical corporation M&A, their taxation implications, and points for tax optimization.

Main Schemes and Tax Treatment for Medical Corporation M&A

1. Transfer of Equity Interests (Medical Corporations with Equity Interests)

The most common method for M&A in medical corporations with equity interests is the “transfer of equity interests,” where existing shareholders (members) transfer their equity interests to the acquirer. The tax treatment for the transferor in this scheme significantly impacts the overall tax burden of the M&A.

Taxation of Transfer Consideration

The consideration received from the transfer of equity interests is, in principle, treated as “capital gains” and is subject to separate taxation. The tax rate is 20.315%, which is the sum of income tax (15.315%) and resident tax (5%). This is a favorable scheme that can significantly reduce the tax burden compared to the maximum progressive tax rate of 55% applied when combined with other income.

Calculation of Acquisition Cost and Capital Gains

In calculating capital gains, the amount obtained by subtracting the “acquisition cost” and “transfer expenses” from the “transfer consideration” is subject to taxation. The acquisition cost generally refers to the actual amount paid to acquire the equity interests. However, many medical corporations with equity interests have been established for a long time, or the initial investment amounts were small. As a result, the acquisition cost is often significantly lower than the transfer consideration, leading to large capital gains.

Risk of Deemed Dividends

Depending on how the transfer consideration is paid, the tax treatment may change. For example, if a corporation repays equity interests as a distribution of surplus, the repaid amount may be considered “dividend income” and subject to comprehensive taxation. Since dividend income is aggregated with other income, if the transfer consideration is high, the tax burden could significantly exceed 20.315%. Therefore, careful tax judgment is essential during the scheme consideration phase.

Comparison of Taxation Methods for Equity Interest Transfer

Taxation Method Overview/Tax Rate Advantage/Disadvantage
Capital Gains (Transfer of Equity Interests) Separate Taxation: 20.315%
(Income Tax 15.315% + Resident Tax 5%)
Most Favorable Option
Retirement Allowance (Retirement Pay Form) 1/2 Taxation, Retirement Income Deduction Available
(Advantageous for over 20 years of service)
Favorable Depending on the Case
Dividend Income/Employment Income Comprehensive Taxation (Up to 55%) Often Disadvantageous

*The above is a general treatment and may vary depending on individual circumstances.

2. Executive Retirement Allowance/Remuneration Scheme (Medical Corporations without Equity Interests)

In the case of medical corporations without equity interests, there is no concept of equity interests, so the transfer of management control is primarily carried out through the change of the chairman of the board or directors. The method of payment for the consideration in this case is an important tax issue.

Payment as Executive Retirement Allowance

A scheme where the transfer consideration is paid as an “executive retirement allowance” to the retiring chairman, etc., may be tax-advantageous. Executive retirement allowances are treated as “retirement income” and, unlike employment income or capital gains, are subject to 1/2 taxation and a retirement income deduction based on years of service, which can reduce the tax burden. This is particularly advantageous for executives with over 20 years of service, as the retirement income deduction becomes larger.

Remuneration under Consulting Agreements, etc.

Another method is to pay part or all of the transfer consideration as remuneration based on a “consulting agreement” concluded with the successor chairman, etc. In this case, the recipient is subject to comprehensive taxation as “employment income.” Compared to the retirement allowance scheme, the tax burden is likely to be heavier, requiring careful consideration.

Other Considerations

It is also necessary to consider the possibility of gift tax or capital gains tax arising depending on the individual circumstances, such as treatment as a donation from a third party or deemed transfer of specific assets. Whichever scheme is chosen, it is important to proceed cautiously in cooperation with experts to meet the legal requirements and avoid tax audits.

3. Business Transfer

This is a method where specific business divisions or assets, such as clinics, are transferred to another medical corporation or a for-profit corporation (e.g., a stock company) without dissolving or liquidating the medical corporation itself. Since the corporate status remains, issues such as the application of corporate reorganization tax laws and the transfer of licenses become points of discussion.

Taxation for the Transferor

The capital gains from a business transfer are subject to “corporate tax” for the transferring medical corporation. The capital gains are taxed as income for that fiscal year, and separate dividend income tax will apply to distributions to shareholders.

Taxation for the Transferee

For the transferee, the acquisition cost of fixed assets (medical equipment, buildings, etc.) among the transferred business assets will be depreciated on an individual asset basis. In addition, “goodwill,” which is not recorded on the balance sheet among the transfer consideration, can generally be amortized equally over 5 years and deducted as an expense.

Consumption Tax Treatment

The treatment of consumption tax in a business transfer varies depending on the transferred assets. The transfer of assets such as medical equipment and facilities is generally subject to taxation, but “provision of services” or “transfer of rights” deemed to be medical licenses or patient lists may be exempt. This classification is complex and requires expert judgment.

4. Merger

A “merger,” which integrates multiple medical corporations into a single entity, is carried out to expand business scale and improve management efficiency through organizational restructuring. Mergers can be either surviving or dissolved mergers. In the case of medical corporations, forms such as a medical corporation without equity interests absorbing one with equity interests, or vice versa, are also conceivable.

Qualified vs. Non-Qualified Mergers

The most important tax issue in mergers is the distinction between “qualified mergers” and “non-qualified mergers.” If a merger meets certain requirements (qualification requirements for corporate reorganization tax laws) and is certified as a “qualified merger,” the assets and liabilities of the merged corporation are comprehensively succeeded, and taxation on unrealized gains is deferred. In other words, it is possible to avoid taxation immediately after the merger and maintain business continuity. On the other hand, if it is determined to be a “non-qualified merger,” the merged corporation is deemed to have transferred its assets at market value, and corporate tax will be levied on the unrealized gains.

Sponsored Links

Specific Issues for Medical Corporations

In the merger of medical corporations, issues other than taxation, such as the succession of licenses, the impact of medical fee revisions, and the division of roles in regional medical planning, are intricately intertwined. In particular, the post-merger operational structure of the medical corporation and changes in the composition of members significantly affect the success of the merger and subsequent business development, requiring careful planning.

Key Tax Issues in Medical Corporation M&A

  • Taxation Method for Transfer Consideration: Classification and tax rates for capital gains, retirement income, dividend income, etc.
  • Valuation of Equity Interests: Calculation of acquisition cost, presence of unrealized gains.
  • Corporate Reorganization Tax Laws: Requirements for qualified mergers, qualified divisions, etc.
  • Consumption Tax: Classification of taxable assets and services.
  • Licenses and Notifications: Procedures with the public health center, welfare bureau, etc.
  • Fund Repayments, etc.: Tax treatment of fund contributions.

Tax Optimization Strategies for the Transferor

In medical corporation M&A, minimizing the tax burden for the transferor is crucial for achieving smooth business succession. Below are key strategies for tax optimization.

1. Tax Rate Reduction Through Prior Incorporation

When selling a privately owned clinic, the capital gains are subject to comprehensive individual income and resident taxes as business income or capital gains. The income tax rate is progressive, potentially reaching a maximum of 55%. In contrast, by establishing a medical corporation in advance and transferring the individual business to that medical corporation via “business transfer,” the transfer consideration becomes subject to corporate tax. Furthermore, by selecting a scheme to transfer the “equity interests” of that medical corporation, as mentioned above, capital gains tax at a separate rate of 20.315% can be applied, significantly reducing the tax burden. This “prior incorporation” strategy is particularly effective when capital gains are substantial.

2. Utilization of Retirement Allowance Schemes

For medical corporations without equity interests, paying the consideration associated with the transfer of management control as an “executive retirement allowance” to the retiring executive may offer tax advantages. Executive retirement allowances are subject to a retirement income deduction based on years of service and 1/2 taxation, generally resulting in a lower tax burden than receiving it as employment income or business income. This is especially beneficial for executives with over 20 years of service, as the retirement income deduction is larger. However, the amount and method of payment of retirement allowances must be within the “reasonable amount” stipulated by tax law; excessively high amounts carry the risk of being disallowed in a tax audit.

3. Optimization of Transfer Timing

Capital gains are taxed as income in the year the transfer occurs. The timing of the M&A execution must be carefully determined, considering the transferor’s individual income situation and the impact of aggregation with other income on the tax burden. For example, executing a transfer in a year where significant income is expected from other businesses could result in an increased tax burden due to the aggregation of capital gains. It is important to consider the optimal transfer timing in alignment with retirement income planning and future asset formation plans.

4. Consideration of Fund Repayments, etc.

Medical corporations may have “funds” contributed. Depending on the M&A scheme, these funds may be repaid. Fund repayments, unlike the repayment of equity interests, are generally not considered taxable income. However, their treatment is complex and must meet tax law requirements. Considering fund repayment simultaneously with the M&A execution may optimize cash flow and tax treatment while suppressing temporary cash outflows.

Points for Transferor Tax Optimization

  1. Incorporation: Tax rate reduction through business transfer from sole proprietorship to medical corporation, and equity interest transfer (20.315%).
  2. Retirement Allowance: Utilization of executive retirement allowances in medical corporations without equity interests (1/2 taxation, retirement income deduction).
  3. Transfer Timing: Avoid aggregation with other income and select a favorable timing.
  4. Fund Repayment: Optimization of cash flow and tax treatment through fund repayment linked to M&A.

Tax and Accounting Issues for the Transferee

The tax and accounting issues for the transferee in medical corporation M&A primarily revolve around the valuation of acquired assets, amortization of goodwill, and the formulation of a business plan based on future profitability forecasts. In particular, careful due diligence (DD) is essential, taking into account the medical fee system, depreciation of medical equipment, and future medical fee revision risks.

1. Valuation and Depreciation of Acquired Assets

The transferee will record the assets (buildings, medical equipment, facilities, etc.) of the acquired medical corporation in their accounting books based on their acquisition cost. These fixed assets will be depreciated based on their useful life under tax law and deducted as expenses. It is important to accurately grasp the impact of depreciation expenses, especially for high-value medical equipment, on future profits. Furthermore, it is advisable to adopt a conservative valuation, considering the risk of future revenue fluctuations due to medical fee revisions.

2. Amortization of Goodwill

In M&A, if the transfer consideration exceeds the net asset value, the difference is recorded as “goodwill.” In medical corporation M&A as well, the portion of the consideration paid by the transferee that exceeds the net asset value of the acquired assets is generally recorded as the intangible fixed asset “goodwill.” This goodwill can be amortized equally over 5 years under tax law and deducted as an expense each period. However, goodwill amortization can also be a factor that weighs down future profits, so its recoverability must be carefully considered in the post-M&A business plan.

3. Succession of Licenses and Notifications

In medical corporation M&A, procedures are required to transfer various licenses and notifications received from public health centers, welfare bureaus, etc., to the transferee. This includes permits for establishing clinics, permits for establishing hospitals, and various designations (e.g., insurance medical institution, workers’ compensation designated medical institution). Since these licenses are fundamental to business continuity, confirmation with the competent authorities and completion of necessary procedures before the M&A execution are essential. Delays or deficiencies in procedures can disrupt business operations.

4. Application of Corporate Reorganization Tax Laws (in case of Mergers/Divisions)

In M&A involving organizational restructuring such as mergers or company divisions, tax deferral is possible by meeting the aforementioned “qualification requirements.” For the transferee, this offers significant tax advantages as they can inherit the assets and liabilities of the merged or divided corporation without recognizing unrealized gains or losses. However, determining qualification requirements is complex and requires thorough prior consideration by experts. If the requirements are not met, it becomes a non-qualified reorganization, carrying the risk of a substantial corporate tax burden.

Transferee M&A Process and Key Issues

1. M&A Strategy Formulation 2. DD & Valuation 3. Tax Scheme Structuring 4. Contract Execution 5. Closing 6. PMI & Integration

The choice of tax scheme in medical corporation M&A significantly impacts the subsequent business performance and available funds for both the transferor and the transferee. Understanding the unique characteristics of medical corporations, which differ from general corporations, and constructing the optimal scheme in collaboration with experts is the key to success. It is necessary to comprehensively consider a wide range of issues, including the valuation of equity interests, taxation implications, corporate reorganization tax laws, and the succession of licenses, and to implement a tax strategy integrated with a forward-looking business plan.

At M&A Medical, our team of experts specializing in medical corporation M&A and business succession provides comprehensive support from structuring the optimal scheme tailored to your situation to its execution. Please feel free to contact us if you have any questions regarding tax, legal, or financial matters, or if you wish to discuss your specific needs. We offer initial consultations free of charge.


For Medical Succession Consultations, Contact M&A Medical

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support everything from the transfer of clinics and medical corporations struggling with a lack of successors to strategic acquisitions on a success fee basis.

  • Initial consultation and preliminary assessment are free
  • No upfront or monthly fees (success fee only)
  • Strict confidentiality (proceeding under NDA)
  • Support available nationwide in all 47 prefectures and for all medical specialties

Please consult with us early, even if you only want to know the market value, have no successor, or are considering joining a group.

Apply for Free Consultation

Related Sponsors

— End of Column —

📧 NEWSLETTER

Medical M&A and Business Succession NewsEvery MondayDelivered (Free, 1 item via email)

Consult for FreeStrictly Confidential, Submit in 1 Minute
Protected by reCAPTCHA · Privacy · Terms